Randomized Controlled Trials as Topic

"Randomized Controlled Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.

Descriptor ID	D016032
MeSH Number(s)	E05.318.760.250.500.365.500 N05.715.360.775.088.500.387.500 N06.850.520.450.250.250.365.500
Concept/Terms	Randomized Controlled Trials as Topic Randomized Controlled Trials as Topic Clinical Trials, Randomized Clinical Trials, Randomized Trials, Randomized Clinical Controlled Clinical Trials, Randomized Controlled Clinical Trials, Randomized

Below are MeSH descriptors whose meaning is more general than "Randomized Controlled Trials as Topic".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Epidemiologic Study Characteristics [E05.318.760]
Clinical Studies as Topic [E05.318.760.250]
Clinical Trials as Topic [E05.318.760.250.500]
Controlled Clinical Trials as Topic [E05.318.760.250.500.365]
Randomized Controlled Trials as Topic [E05.318.760.250.500.365.500]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Epidemiologic Study Characteristics [N05.715.360.775]
Clinical Studies as Topic [N05.715.360.775.088]
Clinical Trials as Topic [N05.715.360.775.088.500]
Controlled Clinical Trials as Topic [N05.715.360.775.088.500.387]
Randomized Controlled Trials as Topic [N05.715.360.775.088.500.387.500]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Epidemiologic Study Characteristics [N06.850.520.450]
Clinical Studies as Topic [N06.850.520.450.250]
Clinical Trials as Topic [N06.850.520.450.250.250]
Controlled Clinical Trials as Topic [N06.850.520.450.250.250.365]
Randomized Controlled Trials as Topic [N06.850.520.450.250.250.365.500]

Below are MeSH descriptors whose meaning is related to "Randomized Controlled Trials as Topic".

Below are MeSH descriptors whose meaning is more specific than "Randomized Controlled Trials as Topic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Randomized Controlled Trials as Topic" by people in this website by year, and whether "Randomized Controlled Trials as Topic" was a major or minor topic of these publications.

Bar chart showing 1185 publications over 30 distinct years, with a maximum of 61 publications in 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	3	5	8
1997	0	6	6
1998	0	6	6
1999	1	12	13
2000	0	14	14
2001	2	11	13
2002	2	18	20
2003	8	32	40
2004	5	43	48
2005	3	40	43
2006	9	45	54
2007	7	32	39
2008	6	41	47
2009	7	44	51
2010	10	49	59
2011	8	38	46
2012	7	47	54
2013	2	53	55
2014	5	43	48
2015	5	34	39
2016	6	41	47
2017	4	48	52
2018	9	52	61
2019	11	44	55
2020	7	53	60
2021	4	49	53
2022	0	46	46
2023	1	37	38
2024	10	45	55
2025	2	13	15

Below are the most recent publications written about "Randomized Controlled Trials as Topic" by people in Profiles.

Castro E, Ellis J, Craigie S, Haltner A, Nazari J, Niyazov A, Samjoo IA. Comparative efficacy and safety of talazoparib plus enzalutamide and other first-line treatments for metastatic castration-resistant prostate cancer. Oncologist. 2025 Mar 10; 30(3).

View in: PubMed
Axeen S, Chen AJ, Lakdawalla DN, Masia N, Niyazov A, Arondekar B, Freedland SJ. Do trial benefits predict real-world gains in metastatic castration resistant prostate cancer. JNCI Cancer Spectr. 2025 Mar 03; 9(2).

View in: PubMed
Spece H, Kurtz MA, Piuzzi NS, Kurtz SM. Patient-reported outcome measures offer little additional value two years after arthroplasty : a systematic review and meta-analysis. Bone Joint J. 2025 Mar 01; 107-B(3):296-307.

View in: PubMed
Anisman E, Ehsanipoor RM, Saccone G, Berghella V. The association of intrapartum IV fluid rates during labor with birth weight. Eur J Obstet Gynecol Reprod Biol. 2025 Apr; 307:268-270.

View in: PubMed
Baudo M, Sicouri S, Yamashita Y, Magouliotis D, Cabrucci F, Carnila S, Ramlawi B. Balloon-versus self-expandable transcatheter aortic valve implantation in small aortic annuli: a meta-analysis of randomized and propensity studies. Cardiovasc Interv Ther. 2025 Jul; 40(3):607-618.

View in: PubMed
Hamaya R, Hara K, Manson JE, Rimm EB, Sacks FM, Xue Q, Qi L, Cook NR. Machine-learning approaches to predict individualized treatment effect using a randomized controlled trial. Eur J Epidemiol. 2025 Feb; 40(2):151-166.

View in: PubMed
Giakas AM, Hohmann AL, Mehta NN, Dambly JM, Lonner JH. The Fragility of Statistical Findings Regarding Hemiarthroplasty Versus Total Hip Arthroplasty for Displaced Femoral Neck Fractures. Orthopedics. 2025 Mar-Apr; 48(2):69-73.

View in: PubMed
Said MR, Zullo F, Gulersen M, Berghella V. Betamethasone dosing interval at 12 or 24?h apart: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2025 Apr; 307:164-169.

View in: PubMed
G?nkan A, Ferreira MY, Vilardo M, Scarcia L, Bocanegra-Becerra JE, Cardoso LJC, Fabrini Paleare LF, de Oliveira Almeida G, Semione G, Ferreira C, Ciccio G, Mujanovic A, Jabbour P, Serulle Y, Nguyen TN, Baron JC. Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials. Stroke. 2025 Mar; 56(3):580-590.

View in: PubMed
Saeed A, Yousuf S, Khan MA, Gangwani MK, Aziz M, Arnab R, Shah J, Kumar A, Schlachterman A, Kowalski T, Kamal F. Biliary stenting with and without endoscopic sphincterotomy in patients with malignant biliary obstruction: meta-analysis of randomized controlled trials. Eur J Gastroenterol Hepatol. 2025 03 01; 37(3):257-262.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement